Comparing the Effectiveness of Bevacizumab to Ranibizumab in Patients with Exudative Age-Related Macular Degeneration. The BRAMD Study

por Schauwvlieghe, A. M. E., Dijkman, G., Hooymans, J. M., Verbraak, F. D., Hoyng, C. B., Dijkgraaf, M. G. W., Peto, T., Vingerling, J. R., Schlingemann, R. O.
Publicado 2016

Genotype‐phenotype correlations of low‐frequency variants in the complement system in renal disease and age‐related macular degeneration

por Geerlings, M.J., Volokhina, E.B., de Jong, E.K., van de Kar, N., Pauper, M., Hoyng, C.B., van den Heuvel, L.P., den Hollander, A.I.
Publicado 2018

Comparing the effectiveness and costs of Bevacizumab to Ranibizumab in patients with Diabetic Macular Edema: a randomized clinical trial (the BRDME study)

por Schauwvlieghe, A.M.E., Dijkman, G., Hooymans, J.M., Verbraak, F.D., Hoyng, C.B., Dijkgraaf, M.G.W., Van Leeuwen, R., Vingerling, J.R., Moll, A.C., Schlingemann, Reinier O.
Publicado 2015